UCHL1 and myeloid sarcoma: Compared to the control group, median CSF GFAP and UCHL1 concentrations were significantly higher among all patients groups compared to controls, p < 0.001, respectively, Table 1., Fig. 1A, B. There was no difference in the CSF concentrations of either molecule between the MS and PN patients.